-
Product Insights
Valorous Offshore Wind Project
Valorous Offshore Wind Project is an offshore wind project located in Celtic Sea, United Kingdom. The project is owned by Simply Blue Energy Ltd; Total New Energies Ltd and is developed by Blue Gem Wind. The project is expected to come online in 2030. Empower your strategies with our Valorous Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Resomelagon in Inflammatory Bowel Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Resomelagon in Inflammatory Bowel Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Resomelagon in Inflammatory Bowel Disease Drug Details: Resomelagon is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in High-Grade Glioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in High-Grade Glioma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in High-Grade Glioma Drug Details: Unesbulin (PTC-596) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Adenocarcinoma Drug Details: Unesbulin (PTC-596) is under development for the treatment...
-
Thematic Analysis
Apparel M&A Deals Q3 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q3 2023 in the Apparel Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zinpentraxin Alfa in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Zinpentraxin Alfa in Crohn's Disease (Regional Enteritis) Drug Details:Zinpentraxin alfa (PRM-151) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Solid Tumor Drug Details: Unesbulin (PTC-596) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Glioblastoma Multiforme (GBM) Drug Details: Unesbulin (PTC-596) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Unesbulin in Anaplastic Astrocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Unesbulin in Anaplastic Astrocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Unesbulin in Anaplastic Astrocytoma Drug Details: Unesbulin (PTC-596) is under development for...